What is Atazanavir-cobicistat (ATV/c)?

Category: Prescription Drugs

Most popular types: Evotaz

false

This is a combination of antiretroviral agents that may be used for treatment/management of HIV.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 2
Moderate 0
Mild 0
None 1

Commonly reported side effects and conditions associated with Atazanavir-cobicistat (ATV/c)

Side effect Patients Percentage
Joint crackling (crepitus) 1

Why patients stopped taking Atazanavir-cobicistat (ATV/c)

Multiple reasons could be selected

Reason Patients Percentage
Side effects too severe 1
See 1 patient who's stopped taking Atazanavir-cobicistat (ATV/c)

Duration

Stopped taking Atazanavir-cobicistat (ATV/c)

Duration Patients Percentage
Less than 1 month 1
Adherence
Adherence Evaluations Percentage
Always 3
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations Percentage
Very hard to take 1
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 2
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 3
Not specified 0

What people switch to and from

Patients started taking Atazanavir-cobicistat (ATV/c) after stopping:

Treatment Patients Percentage
Emtricitabine-Tenofovir disoproxil fumarate (Truvada) 1
Saquinavir (SQV) (Invirase) 1

Patients stopped taking Atazanavir-cobicistat (ATV/c) and switched to:

Treatment Patients Percentage
Atazanavir (ATV) (Reyataz) 1
Emtricitabine-Tenofovir disoproxil fumarate (Truvada) 1
Ritonavir (RTV, /r) (Norvir) 1
Last updated:
There are no evaluations for Atazanavir-cobicistat (ATV/c).